Safety of oral non-selective non-steroidal anti-inflammatory drugs in osteoarthritis: What does the literature say?
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in osteoarthritis. While measured to have a moderate effect on pain in osteoarthritis, NSAIDs have been associated with wide-ranging adverse events affecting the gastrointestinal, cardiovascular, and r...
Autori principali: | Cooper, C, Chapurlat, R, Al-Daghri, N, Herrero-Beaumont, G, Bruyère, O, Rannou, F, Roth, R, Uebelhart, D, Reginster, J |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
Springer International Publishing
2019
|
Documenti analoghi
Documenti analoghi
-
Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)
di: Honvo, G, et al.
Pubblicazione: (2019) -
Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
di: Bruyere, O, et al.
Pubblicazione: (2013) -
Guidelines for the conduct of pharmacological clinical trials in hand osteoarthritis: consensus of a working group of the ESCEO
di: Reginster, J, et al.
Pubblicazione: (2018) -
Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
di: Bruyère, O, et al.
Pubblicazione: (2014) -
Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines
di: Arden, NK, et al.
Pubblicazione: (2020)